Beryl Drugs Limited (BOM:524606)
India · Delayed Price · Currency is INR 21.91
-0.99 (-4.32%)
At close: Jan 20, 2026
Beryl Drugs Market Cap
Beryl Drugs has a market cap or net worth of 112.85 million as of January 23, 2026. Its market cap has decreased by -38.45% in one year.
Market Cap
112.85M
Enterprise Value
155.19M
Revenue
191.97M
Ranking
n/a
PE Ratio
48.04
Stock Price
21.91
Market Cap Chart
Since June 14, 2005, Beryl Drugs's market cap has increased from 3.69M to 112.85M, an increase of 2,954.56%. That is a compound annual growth rate of 18.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 112.85M | -4.91% |
| Dec 31, 2025 | 118.68M | -35.27% |
| Dec 31, 2024 | 183.34M | 63.50% |
| Dec 29, 2023 | 112.14M | 70.08% |
| Dec 30, 2022 | 65.93M | 7.26% |
| Dec 31, 2021 | 61.47M | 54.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sunrest Lifescience | 141.61M |
| Norris Medicines | 139.51M |
| Emmessar Biotech & Nutrition | 127.40M |
| Cian Healthcare | 125.23M |
| Colinz Laboratories | 121.02M |
| Ortin Global | 105.79M |
| Shamrock Industrial Company | 105.25M |
| Unjha Formulations | 96.24M |